General
Preferred name
PYRIDOSTIGMINE
Synonyms
PYRIDOSTIGMINE BROMIDE ()
Pyridostigmine (D6 bromide) ()
mestinon ()
Pyridostigmine iodide ()
Lefaxin ()
Pyridostigmine (bromide) ()
Regonol ()
Pyridostigmini bromidum ()
NSC-679759 ()
NSC-758435 ()
RO-1-5130 ()
Kalimin ()
Mestinon Ret ()
Regonal ()
Kalymin ()
Mestinon 10 ()
Pyridostigmine cation ()
Pyridostigmine ion ()
Pyridostigmine-d3 (bromide) ()
P&D ID
PD010140
CAS
4685-03-4
101-26-8
155-97-5
Tags
available
drug
Approved by
FDA
First approval
1955
Drug Status
investigational
approved
Drug indication
Myasthenia gravis
Discovery agent
Cholinergic
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Pyridostigmine is a peripherally acting, orally active reversible acetylcholinesterase (ACHE) inhibitor, with a slightly longer duration of action than . Marketed formulations contain pyridostigmine bromide (PubChem CID 7550).
(GtoPdb)
DESCRIPTION
Cholinesterase inhibitor
(LOPAC library)
DESCRIPTION
Pyridostigmine is a parasympathomimetic and a reversible cholinesterase inhibitor.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
29
BOC Sciences Bioactive Compounds
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP Approved Drugs
DrugMatrix
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
NPC Screening Collection
Other bioactive compounds
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
ZINC Tool Compounds
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
70
Properties
(calculated by RDKit )
Molecular Weight
181.1
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
0
Rotatable Bonds
1
Ring Count
1
Aromatic Ring Count
1
cLogP
0.57
TPSA
33.42
Fraction CSP3
0.33
Chiral centers
0.0
Largest ring
6.0
QED
0.59
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Selectivity
Cholinesterase
Target
AChE
Acetylcholinesterase
ACHE, BCHE
Cholinesterase (ChE)
AChR
Pathway
Neuronal Signaling
Neuroscience
MOA
Acetylcholinesterase inhibitor
cholinesterase inhibitor
Indication
myasthenia gravis
Therapeutic Class
Parasympathomimetics
Source data